SCHEMBL8069065

SCHEMBL8069065

C[n+]1cccc(C=NO)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 4/20 0.57
ACHE P22303 3/20 0.57
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
HRH1 P35367 1/20 0.44
PDE4D Q08499 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 1/20 0.43
PABPC1 P11940 1/20 0.42
APOBEC3A P31941 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
NNMT P40261 1/20 0.40
CYP1A2 P05177 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8069063 1.00 HDAC8 (0.57) HDAC8ACHELMNAGAATSHR
Iodide SCHEMBL11364255 0.98 HDAC8 (0.55) HDAC8ACHELMNAGAATSHR
Iodide SCHEMBL9501338 0.76 HDAC8 (0.52) HDAC8CYP2C19PABPC1APOBEC3AAPOBEC3G
Iodide SCHEMBL9501333 0.76 HDAC8 (0.52) HDAC8CYP2C19PABPC1APOBEC3AAPOBEC3G
Iodide SCHEMBL9497223 0.74 GAA (0.57) ACHELMNAGAASMN1; SMN2KDM4E
Iodide SCHEMBL9497216 0.74 GAA (0.57) ACHELMNAGAASMN1; SMN2KDM4E
SCHEMBL17399085 0.74 ACHE (0.95) HDAC8ACHEGAATSHRHRH1
SCHEMBL14429827 0.74 ACHE (0.95) HDAC8ACHEGAATSHRHRH1
Iodide SCHEMBL25223680 0.72 ACHE (0.91) HDAC8ACHELMNAGAATSHR
SCHEMBL5162501 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1014981-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME Synapse Pharmaceuticals International, Inc. (CA) 2000-07-05 EP disclosed
WO-1998034615-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1998-08-13 WO disclosed